Resilient field models emphasize continuous territory coverage via agile deployment, blending scalable virtual reach with ...
New data from ADA 2026 reveal that assumptions around age, weight, and gestational history are leaving too many T1D patients ...
In today's Pharmaceutical Executive Daily, the FDA approves Gilead's Trodelvy for the first-line treatment of metastatic ...
In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding ...
Capvaxive uniquely adds eight adult-predominant invasive serotypes absent from other approved pneumococcal vaccines, ...
FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment ...
Approval establishes sacituzumab govitecan as a first-line option across PD-L1 strata, including monotherapy when checkpoint inhibitors are unsuitable and combination therapy for PD-L1 CPS ≥10 tumors.
They want to make sure we've got more control over that supply chain, so DARPA and the federal government are really ...
Clinical Affairs plays a central role in ensuring that CGM promotional claims are accurate, evidence-based, and compliant. By ...
AbbVie entered into an agreement to acquire Apogee Therapeutics at a price of $135.11 for each outstanding. The deal is expected to be worth about $10.9 billion and will add Apogee’s entire pipeline ...
Silvia Taylor of Novavax details how the company leverages its expertise in vaccine development to build partnerships across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results